Cerecin produces Ketasyn which is a molecule for Alzheimer's, Parkinson's, and other age associated memory impairments. The company was founded by Mark Heiman, Samuel Henderson, and Steve Orndorff in 2001, in Denver, Colorado, United States.
The company looks to understand core molecular and cellular processes that contribute to brain development, plasticity, function, and aging.
As of 2020, Cerecin is developing Tricapilin. Tricapilin is an investigational drug for neurological conditions that is meant to assist with Alzheimer's Disease, migraines, Parkinson's Disease, and epilepsy's.
VP of drug development
Accera - Crunchbase Company Profile & Funding
Cerecin | Brain Health
Cerecin | Innovative Brain Health Solutions
Cerecin | Our People
Cerecin | Products and Pipeline
Documentaries, videos and podcasts
Denver, Colorado, United States